Tenaya Therapeutics, Inc. (TNYA)

0.68USD -1.74% (-0.01)

Over 1M: -6.0%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

0.7 0.75
7 Aug 12 Aug 17 Aug 20 Aug 25 Aug 28 Aug 2 Sep

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '25 — Operating Cash Flow: -15.6M Q3 '25 — Free Cash Flow: -15.6M Q4 '25 — Operating Cash Flow: -13.9M Q4 '25 — Free Cash Flow: -14M Q1 '26 — Operating Cash Flow: -19.2M Q1 '26 — Free Cash Flow: -19.2M Q2 '26 — Operating Cash Flow: -3.6M Q2 '26 — Free Cash Flow: -3.7M -16M -12M -8M -4M 0
Q3 '25 Q4 '25 Q1 '26 Q2 '26
Gross Profit Operating Cash Flow Free Cash Flow

How it scores

For a valuation multiple, the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

1.0
SBC / sales 717.3%
Accruals -54.3%
Asset turnover 0.014×
ROA -110.2%
ROCE -142.1%
ROE -148.6%
EBITDA margin —
FCF margin —
Gross margin —
OCF / EBIT —
OCF margin —
OE margin —
Oper. margin —
Profit margin —
ROIC —

1 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
P/C 1.8×
P/B 2.2×
FCF yield -34.2%
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
Fwd P/E —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

0.5
RPO / sales —
RPO growth —
Segment HHI —

0 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

7.3
ND/EBITDA 1.3
Cash runway 1.7 yr
Debt / Eq 0.0×
Debt payback 0.0 yr
Quick ratio 4.5×
Cash / Debt —
F-score —
Interest cover —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

1.0
Shares change +80.4%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —
Sales CAGR 4Y —
Sales Q/Q —
Sales/sh Y/Y —

1 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.